Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| REPLIGEN CORPRGEN · Entity 486 | Chief Financial Officer | May 16, 2023 | May 16, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
REPLIGEN CORP
Report date May 16, 2023 · Filed May 16, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,381 |
Reported balance
After 2023-05-16 transaction · row 1
1 source rowRow 1 · 2023-05-16 · Tax withholding · Disposed 710 · Balance 37,381 F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2020 Filed Nov 11, 2020 02:17 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,086 | $0.00 Strike: $32.40 | $0.00 |
DisclosureSEC source: 0000899243-20-030759 · doc4.xml · derivative · entry 6 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,086 shares Expires 2027-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| November 10, 2020 Filed Nov 11, 2020 02:17 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 3,086 | $193.00 | $595,598.00 |
DisclosureSEC source: 0000899243-20-030759 · doc4.xml · nonDerivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,455 Read SEC document |
| November 10, 2020 Filed Nov 11, 2020 02:17 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 3,086 | $32.40 | $99,986.40 |
DisclosureSEC source: 0000899243-20-030759 · doc4.xml · nonDerivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 02:17 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,893 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-20-030759 · doc4.xml · derivative · entry 5 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,788 Underlying: Common Stock · 1,893 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares vest and become exercisable as follows: 1,894 shares on 2/28/2021 and 1,894 shares on 2/28/2022. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 02:17 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 1,893 | $59.52 | $112,671.36 |
DisclosureSEC source: 0000899243-20-030759 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 02:17 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 705 | $194.69 | $137,256.45 |
DisclosureSEC source: 0000899243-20-030759 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,562 F1 · price: $194.69 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.56 to $194.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 15, 2020 Filed May 20, 2020 00:47 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 660 | $140.43 | $92,683.80 |
DisclosureSEC source: 0000899243-20-013637 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,267 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,024 | $0.00 Strike: $32.40 | $0.00 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · derivative · entry 10 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,086 Underlying: Common Stock · 9,024 shares Expires 2027-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,170 | $0.00 Strike: $26.05 | $0.00 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · derivative · entry 9 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,170 shares Expires 2026-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 846 | $132.37 | $111,985.02 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · nonDerivative · entry 8 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,927 F6 · price: $132.37 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.28 to $132.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 3,013 | $131.38 | $395,847.94 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · nonDerivative · entry 7 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,773 F5 · price: $131.38 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.15 to $131.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,700 | $130.20 | $221,340.00 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · nonDerivative · entry 6 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,786 F4 · price: $130.20 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.80 to $130.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,612 | $128.70 | $207,464.40 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · nonDerivative · entry 5 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,486 F3 · price: $128.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.33 to $129.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,865 | $127.75 | $366,003.75 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · nonDerivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,098 F2 · price: $127.75 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.27 to $128.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 5,358 | $126.77 | $679,233.66 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · nonDerivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,963 F1 · price: $126.77 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.19 to $127.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 9,024 | $32.40 | $292,377.60 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:41 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 3,170 | $26.05 | $82,578.50 |
DisclosureSEC source: 0000899243-20-013283 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 22:53 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,045 | $90.39 | $94,457.55 |
DisclosureSEC source: 0000899243-20-007243 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,127 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F3 · price: $90.39 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.35 to $90.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 22:53 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 610 | $88.18 | $53,789.80 |
DisclosureSEC source: 0000899243-20-007243 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,172 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F2 · price: $88.18 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.15 to $88.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 27, 2020 Filed Mar 3, 2020 00:39 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 4,571 | $0.00 Strike: $44.13 | $0.00 |
DisclosureSEC source: 0000899243-20-006615 · doc4.xml · derivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,571 Underlying: Common Stock · 4,571 shares Expires 2030-02-27 F2 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 27, 2021, February 27, 2022 and February 27, 2023. Read SEC document |
| February 27, 2020 Filed Mar 3, 2020 00:39 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 4,686 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-006615 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,782 F1 · shares: Mr. Snodgres was awarded 4,686 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 22:39 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 946 | $86.11 | $81,460.06 |
DisclosureSEC source: 0000899243-20-006063 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,096 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F3 · price: $86.11 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.75 to $86.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 22:39 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 154 | $86.86 | $13,376.44 |
DisclosureSEC source: 0000899243-20-006063 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,042 F1 · kind: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. F2 · price: $86.86 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.80 to $86.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:17 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,957 | $0.00 Strike: $26.05 | $0.00 |
DisclosureSEC source: 0000899243-19-028777 · doc4.xml · derivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,170 Underlying: Common Stock · 1,957 shares Expires 2026-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:17 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $24.50 | $0.00 |
DisclosureSEC source: 0000899243-19-028777 · doc4.xml · derivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2024-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:17 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 1,957 | $26.05 | $50,979.85 |
DisclosureSEC source: 0000899243-19-028777 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:17 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 2,000 | $24.50 | $49,000.00 |
DisclosureSEC source: 0000899243-19-028777 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 22:09 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 295 | $85.95 | $25,355.25 |
DisclosureSEC source: 0000899243-19-019788 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,239 F1 · shares: Payment of tax liability made via forfeiture of 295 shares of Common Stock valued at a price of $85.95 per share on July 15, 2019. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:50 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-013570 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,534 F1 · shares: Mr. Snodgres was awarded 8,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a five-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 20:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,009 | $59.05 | $59,581.45 |
DisclosureSEC source: 0000899243-19-009025 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,534 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018. F3 · price: $59.05 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.90 to $59.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 20:50 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 5,458 | $58.45 | $319,020.10 |
DisclosureSEC source: 0000899243-19-009025 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,543 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018. F2 · price: $58.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.90 to $58.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 05, 2019 Filed Mar 5, 2019 22:34 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 2,645 | $58.52 | $154,785.40 |
DisclosureSEC source: 0000899243-19-006155 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,001 F2 · kind: Sale of 2,645 shares in the open market to cover tax liability resulting from the release of restricted stock units and PSUs. F3 · price: $58.52 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.28 to $58.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 22:34 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006155 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,646 F1 · shares: Represents shares awarded pursuant to Performance Share Units ("PSUs"). The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria related to the filing of the 2018 Annual Report on Form 10-K, which was filed on March 1, 2019. These PSUs vested on March 1, 2019. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:58 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 5,653 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-19-005889 · doc4.xml · derivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,653 Underlying: Common Stock · 5,653 shares Expires 2029-02-28 F4 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:58 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 1,875 | $58.88 | $110,400.00 |
DisclosureSEC source: 0000899243-19-005889 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,946 F2 · kind: Sale of 1,875 shares in the open market to cover tax liability resulting from the release of restricted stock units. F3 · price: $58.88 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.76 to $59.09 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:58 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 5,922 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-005889 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,821 F1 · shares: Mr. Snodgres was awarded 5,922 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 28, 2019 Filed Jun 11, 2019 23:07 UTC Amendment | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 5,681 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-19-016513 · doc4a.xml · derivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,681 Underlying: Common Stock · 5,681 shares Expires 2029-02-28 F1 · derivative.exercise_date: One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:43 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,253 | $0.00 Strike: $26.05 | $0.00 |
DisclosureSEC source: 0000899243-18-029744 · doc4.xml · derivative · entry 9 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,127 Underlying: Common Stock · 10,253 shares Expires 2026-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Shares vest and become exercisable as follows: 5,126 shares on 2/26/2017, 5,127 shares on 2/26/2018 and 5,127 shares on 2/26/2019. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:43 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,055 | $0.00 Strike: $32.40 | $0.00 |
DisclosureSEC source: 0000899243-18-029744 · doc4.xml · derivative · entry 8 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,110 Underlying: Common Stock · 6,055 shares Expires 2027-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 6,055 shares vest and become exercisable on each of the following dates: 2/23/2018, 2/23/2019 and 2/23/2020. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:43 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $24.50 | $0.00 |
DisclosureSEC source: 0000899243-18-029744 · doc4.xml · derivative · entry 7 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 4,000 shares Expires 2024-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 2,000 shares vest and become exercisable on each of the following dates: 7/14/2015, 7/14/2016, 7/14/2017, 7/14/2018 and 7/14/2019. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:43 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,445 | $0.00 Strike: $26.20 | $0.00 |
DisclosureSEC source: 0000899243-18-029744 · doc4.xml · derivative · entry 6 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,445 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:43 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 31,753 | $63.49 | $2,015,915.41 |
DisclosureSEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 5 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,899 F1 · shares: Sale of common stock was effective pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018. F2 · price: $63.4874 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.18 to $64.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:43 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 10,253 | $26.05 | $267,090.65 |
DisclosureSEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 4 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:43 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 6,055 | $32.40 | $196,182.00 |
DisclosureSEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 3 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:43 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 4,000 | $24.50 | $98,000.00 |
DisclosureSEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:43 UTC | REPLIGEN CORP RGEN · Entity 486 | Exercise / conversionCommon Stock | 11,445 | $26.20 | $299,859.00 |
DisclosureSEC source: 0000899243-18-029744 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2018 Filed Aug 29, 2018 20:15 UTC | REPLIGEN CORP RGEN · Entity 486 | SaleCommon Stock | 14,460 | $52.79 | $763,359.31 |
DisclosureSEC source: 0000899243-18-023467 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,899 F1 · price: $52.7911 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.545 to $52.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 18, 2018 Filed Jul 20, 2018 12:04 UTC | REPLIGEN CORP RGEN · Entity 486 | Tax withholdingCommon Stock | 295 | $47.91 | $14,133.75 |
DisclosureSEC source: 0001140361-18-032952 · doc1.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,359 F1 · shares: Payment of tax liability made via forfeiture of 295 shares of Common Stock valued at a price of $47.911 per share on July 18, 2018. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 02:38 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantStock Option (Right to Buy) · Derivative | 20,659 | $0.00 Strike: $33.87 | $0.00 |
DisclosureSEC source: 0001140361-18-012134 · doc1.xml · derivative · entry 2 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,659 Underlying: Common Stock · 20,659 shares Expires 2028-03-01 F2 · derivative.exercise_date: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 02:38 UTC | REPLIGEN CORP RGEN · Entity 486 | GrantCommon Stock | 10,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-012134 · doc1.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,654 F1 · shares: Mr. Snodgres was awarded 10,680 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.